Testing the Interplay of Gambling, Emotion and Reward

NCT ID: NCT06122298

Last Updated: 2025-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-27

Study Completion Date

2028-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background The nature and direction of dysfunctional reward processing in gambling disorder remains unclear. We aim to test a novel neurobiological model of gambling addiction, that takes into account inter-individual differences, as well as the multifactorial nature of gaming addiction.

Objectives

Primary objective:

This project will test the hypothesis that there are two opposite brain phenotypes that characterize two distinct subpopulations of gamblers, so-called impulsive vs. emotional, respectively.

Secondary objective:

This project will also seek to determine whether the brain phenotypes proposed above are capable of predicting gambling behavior outside the laboratory.

Study design The primary objective will be tested using a reward task and a facial emotion recognition task performed by participants in an fMRI scanner.

The secondary objective will be tested by combining fMRI measures with behavioral measures from everyday life collected via Ecological Momentary Assessment (EMA).

Study population This study will focus on individuals with gambling problems, as well healthy subjects with no gambling problems and no psychiatric comorbidities.

Outcomes/Endpoints

Primary endpoint:

We will compare striatum and amygdala reactivity between the three groups of impulsive gamblers, emotional gamblers and healthy subjects.

Secondary endpoint:

We will assess the correlation between emotional states and gambling behavior in everyday life, based on striatum and amygdala reactivity, using multiple linear regression models.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background Gambling addiction has often been conceptualized as the result of reward processing dysfunction in the brain, particularly in the striatum, a key structure of the reward system. Although a number of studies have provided support for this hypothesis, neuroimaging studies have produced inconsistent results, suggesting either hypo- or hyper-reactivity to rewards in gambling addiction. These inconsistencies have been the subject of intense debate, but remain unexplained to this day, hampering our understanding of the disease and the development of effective therapeutic strategies. The aim of this project is to test a new neurobiological model of gambling addiction that has the potential to reconcile these inconsistencies. A particular feature of this model is that it takes into account inter-individual differences, as well as the multifactorial nature of gaming addiction.

Objectives

Primary objective:

This project will test the hypothesis that there are two opposite brain phenotypes in gambling addiction: striatal hyper-reactivity to reward combined with amygdala hypo-reactivity to emotional stimuli, and striatal hypo-reactivity to reward combined with amygdala hyper-reactivity to emotional stimuli. The investigators further hypothesize that these two brain phenotypes characterize two distinct subpopulations of gamblers, so-called impulsive vs. emotional, respectively.

Secondary objective:

This project will also seek to determine whether the brain phenotypes proposed above are capable of predicting gambling behavior outside the laboratory. To do this, the investigators will use Ecological Momentary Assessment (EMA), which involves using participants' smartphones to perform repeated, real-time sampling of their gambling behavior and emotions in real life. The investigators hypothesize that a significant difference in reactivity between the striatum and the amygdala will be associated with a strong correlation between 1) gambling behavior and positive emotions in impulsive gamblers, and 2) gambling behavior and negative emotions in emotional gamblers.

Study design The primary hypothesis will be tested using cognitive tasks performed by participants in an fMRI scanner. In order to assess striatal reactivity to reward, the investigators will use fMRI combined with a reward task. The investigators will use fMRI combined with a facial emotion recognition task to measure the reactivity of the amygdala to emotional stimuli. These tasks will allow the investigators to establish the brain phenotypes characterizing impulsive and emotional gamblers, and test the hypothesis that these phenotypes are diametrically opposed in these two sub-populations.

The secondary hypothesis will be tested by combining fMRI measures with behavioral measures from everyday life (EMA). In concrete terms, gamblers will be followed longitudinally for up to 4 weeks, and will receive short questionnaires 3 to 4 times a day on their smartphones to assess their gambling behavior (number of hours spent gambling, amount of money spent...) as well as their emotions (positive and negative). These measurements will enable the investigators to test the hypothesis that the brain phenotypes described above are capable of predicting the relationship between emotions and gambling behavior in everyday life.

Study population This study will focus on individuals with gambling problems. This category includes individuals suffering from gambling addiction as defined by the DSM-5, and individuals suffering from "problem gambling", just below the DSM-5 diagnostic threshold. Extending recruitment to individuals with problem gambling should facilitate recruitment, while considering the existence of a continuum of gambling problems.

The study will also include a control group of healthy subjects with no gambling problems and no psychiatric comorbidities.

The plan is to recruit 60 gamblers and 60 healthy controls.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gambling Addiction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Individuals with gambling problems

This group includes individuals suffering from gambling addiction as defined by the DSM-5, and individuals suffering from "problem gambling", just below the DSM-5 diagnostic threshold.

fMRI

Intervention Type OTHER

A brain imaging technique that measures in vivo the activity of brain areas by detecting local changes in blood flow.

Ecological Momentary Assessment

Intervention Type OTHER

studies people's thoughts and behaviour in their daily lives by repeatedly collecting data in an individual's normal environment, at or close to the time they carry out that behaviour

Healthy control individuals

Matched healthy individuals

fMRI

Intervention Type OTHER

A brain imaging technique that measures in vivo the activity of brain areas by detecting local changes in blood flow.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fMRI

A brain imaging technique that measures in vivo the activity of brain areas by detecting local changes in blood flow.

Intervention Type OTHER

Ecological Momentary Assessment

studies people's thoughts and behaviour in their daily lives by repeatedly collecting data in an individual's normal environment, at or close to the time they carry out that behaviour

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

EMA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For all participants (gamblers and healthy subjects)

* Aged between 18 and 65
* Fluent French, read and spoken
* Male and Female
* Informed consent to take part in the research

For gamblers :

* Number of DSM-5 critera for gambling disorder ≥3
* Score ≥ 5 on the Problem Gambling Severity Index questionnaire (PGSI)
* Have a smartphone

For healthy subjects :

* no DSM-5 criteria for gambling addiction
* Score ≤ 2 on the Problem Gambling Severity Index questionnaire (PGSI)

Exclusion Criteria

For all participants (gamblers and healthy subjects):

* Contra-indication to MRI
* Protected Adults
* Breast feeding or pregnant women
* Neurological disorder or severe chronic illness (diabetes, heart disease, kidney disease, lung disease or liver disease, inflammatory disease….)
* Pharmacological treatment with psychotropic action (\>1 time / week)
* Regular drug use (\> 1 time/ week for at least 3 months in the last 6 months)
* Positive urine drug test on the day of the MRI sessions

For gamblers:

* Psychiatric treatment \> 1 month (pharmacological or CBT)
* Other DSM-5 diagnosis : schizophrenia, bipolar disorder, ADHD, autism, current PTSD, eating disorders, current major depressive episode, anxiety disorder, substance use disorder except nicotine, obsessive compulsive disorder.

For healthy subjects :

\- Any DSM-5 diagnosis except nicotine addiction
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role collaborator

Hôpital le Vinatier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume SESCOUSSE, PHD

Role: PRINCIPAL_INVESTIGATOR

CH Le Vinatier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH le Vinatier

Bron, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guillaume SESCOUSSE, PHD

Role: CONTACT

0437915531 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

SESCOUSSE Guillaume, PhD

Role: primary

0437915565 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A00597-38

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain and Mindfulness
NCT03117478 COMPLETED NA
Brain Injury and Cognitive Function
NCT05922748 RECRUITING NA
Reliability of the Human Brain Connectome
NCT02193425 COMPLETED EARLY_PHASE1